Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript
Pulmonx Corporation (NASDAQ:LUNG) Q4 2024 Results Conference Call February 19, 2025 4:30 PM ET Company Participants Elizabeth Sparicio - Investor...
Lung
Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)
Michal Krakowiak/E+ via Getty Images Topline Summary and Update When I last wrote about Summit Therapeutics (NASDAQ:SMMT) back around the...
